Amedisys Reports Fourth Quarter and Year End 2018 Financial Results Issues 2019 Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Amedisys Reports Fourth Quarter and Year End 2018 Financial Results Issues 2019 Guidance

Amedisys (AMED) PT Lowered to $124 at Craig-Hallum

February 28, 2019 3:52 PM EST

Craig-Hallum analyst Kevin Ellich lowered the price target on Amedisys (NASDAQ: AMED) to $124.00 (from $132.00) while maintaining a Hold rating.

Ellich notes FY19 guidance was lower partially due to CCH integration.

... More

Amedisys (AMED) Tops Q4 EPS by 6c, Offers FY Guidance

February 27, 2019 5:02 PM EST

Amedisys (NASDAQ: AMED) reported Q4 EPS of $0.91, $0.06 better than the analyst estimate of $0.85. Revenue for the quarter came in at $434.4 million versus the consensus estimate of $427.51 million.

GUIDANCE:

Amedisys sees FY2019 EPS of $3.98-$4.09, versus the consensus of $4.08. Amedisys sees... More